TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has entered into an agreement with Shoppers Drug Mart Inc. (“Shoppers Drug Mart”) for the over-the-counter (“OTC”) sale of the HeartCheck™ ECG PEN device in pharmacies across Canada. The HeartCheck™ ECG PEN has passed regulatory reviews by both Health Canada and the US Food and Drug Administration as the only OTC ECG displaying device personal heart-health monitoring solution available without a physician’s prescription.
The HeartCheck™ PEN will be made available in approximately 602 Shoppers Drug Mart Pharmacies by February 2015 which will coincide with the start of Heart Month. The product will be placed within the diabetes and high blood pressure monitoring devices section of the store planogram.
The HeartCheck™ PEN ECG can store 20 ECG recordings in memory which can be transferred to a computer for review and management. Consumers purchasing the device will have access to the Company’s free GEMS™ Home software and a free first ECG interpretation through the CardioComm Solutions’ SMART Monitoring ECG service. Sales will target those consumers, and their family, who are interested in the preservation of their heart health as well as those at risk for developing arrhythmias due to underlying conditions, especially prior heart attack, prior cardiac surgery, high blood pressure, high cholesterol, heart failure, diabetes and those taking medications that cause arrhythmias.
CardioComm Solutions has been working with pharmacy banner groups to expand introduction of ECG self-screening and monitoring into the consumer market. The HeartCheck™ PEN is as a groundbreaking and proven medical device that meets the pharmacies’ objective of enhancing personalized heart-health monitoring and betterment of their customers’ health.
More information regarding the HeartCheck™ products and SMART monitoring solutions is available at the Company’s web site www.theheartcheck.com.